Context Therapeutics Inc. (CNTX) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q1 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Hermès can regain momentum despite China weakness, Jefferies says
- Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
